PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm to Present at Evercore ISI HealthCONx Conference, page-134

  1. 680 Posts.
    lightbulb Created with Sketch. 67

    The short term thesis has changed for me also. Looks like plenty of time to come back for the super gains.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.